120 related articles for article (PubMed ID: 21997301)
1. Medical versus surgical abortion methods for pregnancy in China: a cost-minimization analysis.
Xia W; She S; Lam TH
Gynecol Obstet Invest; 2011; 72(4):257-63. PubMed ID: 21997301
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.
Hu D; Grossman D; Levin C; Blanchard K; Goldie SJ
BJOG; 2009 May; 116(6):768-79. PubMed ID: 19432565
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
Jensen JT; Harvey SM; Beckman LJ
Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
[TBL] [Abstract][Full Text] [Related]
4. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
5. Early pregnancy termination with mifepristone and misoprostol in the United States.
Spitz IM; Bardin CW; Benton L; Robbins A
N Engl J Med; 1998 Apr; 338(18):1241-7. PubMed ID: 9562577
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Li L; Zhou Z; Huang L
Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
9. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
[TBL] [Abstract][Full Text] [Related]
11. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Creinin MD; Shore E; Balasubramanian S; Harwood B
Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
[TBL] [Abstract][Full Text] [Related]
12. [Study on the influence of medical abortion and surgical abortion on subsequent pregnancy].
Zou Y; Luo J; Xiao YF; Fan YJ; Luo R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):543-5. PubMed ID: 15291123
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
[TBL] [Abstract][Full Text] [Related]
15. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
16. Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference?
Goodyear-Smith F; Knowles A
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):211-5. PubMed ID: 19432614
[TBL] [Abstract][Full Text] [Related]
17. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
Singh K; Fong YF; Dong F
BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
19. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
20. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
Rørbye C; Nørgaard M; Nilas L
Contraception; 2004 Nov; 70(5):393-9. PubMed ID: 15504379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
